TVAX Biomedical is performing phase II/III clinical trials to determine the safety and efficacy of a natural immunological cancer treatment that has proven to be safe and effective during previous phase I/IIa studies.
TVAX is testing its treatment against advanced brain cancer and advanced kidney cancer.
TVAX Immunotherapy manipulates the immune system to generate immune cells that kill and eliminate cancer cells from the body.